{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:26:33Z","timestamp":1787142393349,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jaad.2026.05.043","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:11:26Z","timestamp":1779376286000},"page":"680-689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Linagliptin is a risk factor for bullous pemphigoid associated with BP180-NC16A\/BP230 seronegativity and milder severity: Evidence from a prospective case-control study supporting ECD-BP180 enzyme-linked immunosorbent assay in reducing diagnostic delay"],"prefix":"10.1016","volume":"95","author":[{"given":"Anna","family":"Pira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Salemme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feliciana","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sampogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo Linda Maria","family":"Sinagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Di Campli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Collina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Giampetruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Sanjust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabatino","family":"Pallotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Panebianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"Didona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Pitocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara De","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Abeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Zenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Salemme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feliciana","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sampogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo Linda","family":"Maria Sinagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Di Campli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Collina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Provini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Giampetruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Zanniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Palermi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Teofoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Scalise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Chiloiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ippoliti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Ballesio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flaminia","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Sanjust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Tonanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Sgadari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabatino","family":"Pallotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Panebianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"Didona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Pitocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Abeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Zenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.05.043_bib1","first-page":"995","article-title":"Incidence of autoimmune bullous diseases in Serbia: a 20-year retrospective study","volume":"14","author":"Milinkovi\u0107","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2026.05.043_bib2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00403-017-1778-4","article-title":"Incidence of bullous pemphigoid in Sweden 2005-2012: a nationwide population-based cohort study of 3761 patients","volume":"309","author":"Thorslund","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2026.05.043_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clindermatol.2011.03.005","article-title":"Bullous pemphigoid: from the clinic to the bench","volume":"30","author":"Di Zenzo","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib4","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3389\/fimmu.2019.01506","article-title":"New insights into the pathogenesis of bullous pemphigoid: 2019 update","volume":"10","author":"Genovese","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaad.2026.05.043_bib5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/1523-1747.ep12337492","article-title":"Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies","volume":"109","author":"Zillikens","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib6","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1365-2133.2004.06245.x","article-title":"Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients","volume":"151","author":"Mariotti","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clim.2008.04.012","article-title":"Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid","volume":"128","author":"Di Zenzo","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaad.2026.05.043_bib8","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/jdv.14312","article-title":"Multimorbidity in bullous pemphigoid: a case-control analysis of bullous pemphigoid patients with age- and gender-matched controls","volume":"31","author":"Sim","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.05.043_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1684\/ejd.2010.0805","article-title":"Bullous pemphigoid and internal diseases - A case-control study","volume":"20","author":"Jedlickova","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1590\/abd1806-4841.20142516","article-title":"Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients","volume":"89","author":"Teixeira","year":"2014","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib11","first-page":"195","article-title":"Spectrum of autoimmune bullous diseases in Northern Greece. A 4-year retrospective study and review of the literature","volume":"25","author":"Patsatsi","year":"2017","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.jaad.2026.05.043_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/bjd.14601","article-title":"Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database","volume":"175","author":"B\u00e9n\u00e9","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000480498","article-title":"Use of dipeptidyl-peptidase IV inhibitors and bullous pemphigoid","volume":"233","author":"Schaffer","year":"2017","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2026.05.043_bib14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jaad.2017.09.051","article-title":"Detection and characterization of IgG, IgE, and IgA autoantibodies in patients with bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors","volume":"78","author":"Fania","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib15","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1111\/jdv.14957","article-title":"Changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase-4 inhibitors","volume":"32","author":"Gravani","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.05.043_bib16","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1111\/jdv.14649","article-title":"Increased prevalence of diabetes mellitus in bullous pemphigoid patients during the last decade","volume":"32","author":"Fania","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.05.043_bib17","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1111\/jdv.14965","article-title":"Commentary on \u2018changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase-4 inhibitors\u2019","volume":"32","author":"Fania","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.05.043_bib18","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jid.2018.01.027","article-title":"Vildagliptin significantly increases the risk of bullous pemphigoid: a Finnish Nationwide Registry Study","volume":"138","author":"Varpuluoma","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3315\/jdcr.2014.1166","article-title":"Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature","volume":"8","author":"Attaway","year":"2014","journal-title":"J Dermatol Case Rep"},{"key":"10.1016\/j.jaad.2026.05.043_bib20","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1111\/ajd.13100","article-title":"Dipeptidyl peptidase-4 inhibitors and bullous pemphigoid: a systematic review and adjusted meta-analysis","volume":"61","author":"Phan","year":"2020","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib21","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jdi.14004","article-title":"Risk heterogeneity of bullous pemphigoid among dipeptidyl peptidase-4 inhibitors: a population-based cohort study using Japanese Latter-Stage Elderly Healthcare Database","volume":"14","author":"Harano","year":"2023","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jaad.2026.05.043_bib22","doi-asserted-by":"crossref","first-page":"adv26663","DOI":"10.2340\/actadv.v104.26663","article-title":"Identification of risk factors for gliptin-associated bullous pemphigoid among diabetic patients","volume":"104","author":"Shalmon","year":"2024","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2026.05.043_bib23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jid.2018.10.045","article-title":"Higher frequency of dipeptidyl peptidase-4 inhibitor intake in bullous pemphigoid patients than in the French general population","volume":"139","author":"Plaquevent","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib24","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2340\/00015555-3166","article-title":"Gliptin-associated bullous pemphigoid and the expression of dipeptidyl peptidase-4\/CD26 in bullous pemphigoid","volume":"99","author":"Lindgren","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2026.05.043_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40257-020-00563-7","article-title":"More severe erosive phenotype despite lower circulating autoantibody levels in dipeptidyl peptidase-4 inhibitor (DPP4i)-associated bullous pemphigoid: a retrospective cohort study","volume":"22","author":"St\u00e4nder","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316786","article-title":"From molecular insights to clinical perspectives in drug-associated bullous pemphigoid","volume":"24","author":"de Nicolas-Ruanes","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaad.2026.05.043_bib27","first-page":"305","article-title":"Bullous pemphigoid: Italian guidelines adapted from the EDF\/EADV guidelines","volume":"153","author":"Cozzani","year":"2018","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.05.043_bib28","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Authors\/Task Force Members","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaad.2026.05.043_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaad.2022.02.036","article-title":"Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: results of a multicenter study","volume":"87","author":"Salemme","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1494294","article-title":"Bullous pemphigoid and mucous membrane pemphigoid humoral responses differ in reactivity towards BP180 midportion and BP230","volume":"15","author":"Mariotti","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaad.2026.05.043_bib31","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaad.2017.12.038","article-title":"Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: retrospective multicenter case-control study from France and Switzerland","volume":"78","author":"Benzaquen","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib32","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/jdi.12877","article-title":"Dipeptidyl peptidase-4 inhibitors-associated bullous pemphigoid: a retrospective study of 168 pemphigoid and 9,304 diabetes mellitus patients","volume":"10","author":"Kawaguchi","year":"2019","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jaad.2026.05.043_bib33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/1346-8138.16394","article-title":"Clinical features of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid in Japan: a nationwide retrospective observational study","volume":"49","author":"Sugiyama","year":"2022","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/bjd\/ljae172","article-title":"Programmed death receptor-1 and programmed death ligand-1 checkpoint inhibition-associated bullous pemphigoid: a propensity-matched retrospective cohort study","volume":"191","author":"Sarkovics","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib35","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jamadermatol.2018.2352","article-title":"Association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors in patients with diabetes: estimating the risk of the new agents and characterizing the patients","volume":"154","author":"Kridin","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/1346-8138.14741","article-title":"Analysis of patients with drug-induced pemphigoid using the Japanese Adverse Drug Event Report database","volume":"46","author":"Tanaka","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/1346-8138.15195","article-title":"Increased risk of bullous pemphigoid in dipeptidyl peptidase 4 inhibitors: a nationwide, population-based, cohort study in Taiwan","volume":"47","author":"Hung","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib38","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00403-023-02562-0","article-title":"Prevalence of diabetes mellitus in bullous pemphigoid patients in the absence of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis","volume":"315","author":"Guo","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2026.05.043_bib39","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/ijd.16970","article-title":"Bullous pemphigoid and diabetes mellitus: a systematic review and meta-analysis","volume":"63","author":"Jiirasutat","year":"2024","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib40","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12020-020-02272-x","article-title":"Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials","volume":"69","author":"Silverii","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.jaad.2026.05.043_bib41","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/jid.2011.180","article-title":"Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study","volume":"131","author":"Di Zenzo","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib42","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3389\/fimmu.2018.00779","article-title":"Humoral epitope spreading in autoimmune bullous diseases","volume":"9","author":"Didona","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaad.2026.05.043_bib43","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jid.2016.06.622","article-title":"Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid","volume":"136","author":"Izumi","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib44","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2169\/internalmedicine.0815-22","article-title":"Clinical phenotypes and the clinical course of bullous pemphigoid receiving dipeptidyl pepitidase-4 inhibitor treatment: an analysis of cases in a single Japanese Center","volume":"62","author":"Nakagawa","year":"2023","journal-title":"Intern Med"},{"key":"10.1016\/j.jaad.2026.05.043_bib45","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/archderm.1978.01640230013003","article-title":"Bullous pemphigoid: therapy in patients with and without diabetes mellitus","volume":"114","author":"Downham","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2018.02.080","article-title":"Bullous pemphigoid and diabetes mellitus: Are we missing the larger picture?","volume":"79","author":"Geller","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib47","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.4049\/jimmunol.176.3.2015","article-title":"Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230","volume":"176","author":"Thoma-Uszynski","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2026.05.043_bib48","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jid.2015.11.030","article-title":"Epitope-dependent pathogenicity of antibodies targeting a major bullous pemphigoid autoantigen collagen XVII\/BP180","volume":"136","author":"Wada","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib49","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/exd.13331","article-title":"Autoantibodies of non-inflammatory bullous pemphigoid hardly deplete type XVII collagen of keratinocytes","volume":"26","author":"Imafuku","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib50","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/bjd.16479","article-title":"Unique clinical and serological features of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors","volume":"178","author":"Horikawa","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.05.043_bib51","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/1346-8138.14245","article-title":"Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid","volume":"45","author":"Chijiwa","year":"2018","journal-title":"J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226027210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226027210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:41:26Z","timestamp":1787139686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226027210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0190962226027210"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.05.043","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linagliptin is a risk factor for bullous pemphigoid associated with BP180-NC16A\/BP230 seronegativity and milder severity: Evidence from a prospective case-control study supporting ECD-BP180 enzyme-linked immunosorbent assay in reducing diagnostic delay","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.05.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}